The BRAF Inhibitor Vemurafenib Activates Mitochondrial Metabolism and Inhibits Hyperpolarized Pyruvate-Lactate Exchange in BRAF-Mutant Human Melanoma Cells. (2016)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/1535-7163.MCT-16-0068

PubMed Identifier: 27765851

Publication URI: http://europepmc.org/abstract/MED/27765851

Type: Journal Article/Review

Volume: 15

Parent Publication: Molecular cancer therapeutics

Issue: 12

ISSN: 1535-7163